Life Science Institute, Inc.

Outline

Company name Life Science Institute, Inc.
Head office THE KAITEKI Building, 13‐4 Uchikanda 1‐chome, Chiyoda‐ku, Tokyo 101‐0047
Representative President & CEO Seiichi Kiso
Date of incorporation April 1, 2014
Paid-in capital 9,250 million yen
Line of business (consolidated) Next-generation Healthcare, Healthcare and Medical ICT, and Pharmaceutical Development Solutions
Sales revenue (Consolidated) 23.2 billion(FY2020)
Employees (Consolidated) 562(As of March 31, 2021)
Shareholder Mitsubishi Chemical Holdings Corporation 100%